• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁状态与慢性血液透析患者生存的关系。

Association between Iron Status and Survival in Patients on Chronic Hemodialysis.

机构信息

Division of Nephrology, Department of Internal Medicine, Yeungnam University Medical Center, 170 Hyeonchung-Ro, Nam-Gu, Daegu 42415, Republic of Korea.

Health Insurance Review and Assessment Service, 60 Hyeoksin-Ro, Wonju-si 26465, Republic of Korea.

出版信息

Nutrients. 2023 May 31;15(11):2577. doi: 10.3390/nu15112577.

DOI:10.3390/nu15112577
PMID:37299540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10255805/
Abstract

The aim of this study was to evaluate survival rates according to iron status in patients undergoing maintenance hemodialysis (HD). Thus, the National HD Quality Assessment Program dataset and claims data were used for analysis ( = 42,390). The patients were divided into four groups according to their transferrin saturation rate and serum ferritin levels: Group 1 ( = 34,539, normal iron status); Group 2 ( = 4476, absolute iron deficiency); Group 3 ( = 1719, functional iron deficiency); Group 4 ( = 1656, high iron status). Using univariate and multivariable analyses, Group 1 outperformed the three other groups in terms of patient survival. Using univariate analysis, although Group 2 showed a favorable trend in patient survival rates compared with Groups 3 and 4, the statistical significance was weak. Group 3 exhibited similar patient survival rates to Group 4. Using multivariable Cox regression analysis, Group 2 had similar patient survival rates to Group 3. Subgroup analyses according to sex, diabetic status, hemoglobin level ≥ 10 g/dL, and serum albumin levels ≥ 3.5 g/dL indicated similar trends to those of the total cohort. However, subgroup analysis based on patients with a hemoglobin level < 10 g/dL or serum albumin levels < 3.5 g/dL showed a weak statistical significant difference compared with those with hemoglobin level ≥ 10 g/dL, or serum albumin levels ≥ 3.5 g/dL. In addition, the survival difference between Group 4 and other groups was greater in old patients than in young ones. Patients with a normal iron status had the highest survival rates. Patient survival rates were similar or differed only modestly among the groups with abnormal iron status. In addition, most subgroup analyses revealed similar trends to those according to the total cohort. However, subgroup analyses based on age, hemoglobin, or serum albumin levels showed different trends.

摘要

本研究旨在评估接受维持性血液透析(HD)患者的生存率与铁状态的关系。为此,我们使用了国家 HD 质量评估计划数据集和索赔数据进行分析(n=42390)。根据转铁蛋白饱和度和血清铁蛋白水平,患者被分为四组:组 1(n=34539,铁状态正常);组 2(n=4476,绝对缺铁);组 3(n=1719,功能性缺铁);组 4(n=1656,高铁状态)。使用单变量和多变量分析,组 1 在患者生存率方面优于其他三组。使用单变量分析,尽管组 2 的患者生存率较组 3 和组 4 有较好的趋势,但统计学意义较弱。组 3 的患者生存率与组 4 相似。使用多变量 Cox 回归分析,组 2 的患者生存率与组 3 相似。根据性别、糖尿病状态、血红蛋白水平≥10g/dL 和血清白蛋白水平≥3.5g/dL 的亚组分析显示出与总队列相似的趋势。然而,基于血红蛋白水平<10g/dL 或血清白蛋白水平<3.5g/dL 的患者的亚组分析与血红蛋白水平≥10g/dL 或血清白蛋白水平≥3.5g/dL 的患者相比,差异具有统计学意义。此外,与血红蛋白水平≥10g/dL 或血清白蛋白水平≥3.5g/dL 的患者相比,老年患者组 4 与其他组之间的生存差异更大。铁状态正常的患者具有最高的生存率。铁状态异常的各组之间的生存率相似或略有差异。此外,大多数亚组分析显示出与总队列相似的趋势。然而,基于年龄、血红蛋白或血清白蛋白水平的亚组分析显示出不同的趋势。

相似文献

1
Association between Iron Status and Survival in Patients on Chronic Hemodialysis.铁状态与慢性血液透析患者生存的关系。
Nutrients. 2023 May 31;15(11):2577. doi: 10.3390/nu15112577.
2
Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.低水平血清铁蛋白和中度转铁蛋白饱和度可使血液透析患者血红蛋白水平充足,回顾性观察研究。
PLoS One. 2017 Jun 29;12(6):e0179608. doi: 10.1371/journal.pone.0179608. eCollection 2017.
3
The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data.铁在接受促红细胞生成素α和静脉铁治疗的维持性血液透析患者长期生存中的重要性:对9.5年前瞻性收集数据的分析
BMC Nephrol. 2009 Feb 26;10:6. doi: 10.1186/1471-2369-10-6.
4
Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis.促红细胞生成素、铁缺乏与相对性血小板增多症:血液透析中血红蛋白生存悖论的一种可能解释
Am J Kidney Dis. 2008 Oct;52(4):727-36. doi: 10.1053/j.ajkd.2008.05.029. Epub 2008 Aug 29.
5
Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.血清可溶性转铁蛋白受体反映了促红细胞生成素治疗的慢性血液透析患者的红细胞生成情况,但不能反映铁的可利用性。
Clin Nephrol. 2002 Nov;58(5):363-9. doi: 10.5414/cnp58363.
6
Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.网织红细胞血红蛋白含量可预测接受重组人促红细胞生成素治疗的血液透析患者的功能性缺铁。
Am J Kidney Dis. 1997 Dec;30(6):912-22. doi: 10.1016/s0272-6386(97)90104-9.
7
Current management of anemia in adult hemodialysis patients with end-stage renal disease.成人终末期肾病血液透析患者贫血的当前管理。
Am J Health Syst Pharm. 2002 Mar 1;59(5):429-35. doi: 10.1093/ajhp/59.5.429.
8
[Iron replacement in hemodialysis patients with a normal serum ferritin level].[血清铁蛋白水平正常的血液透析患者的铁补充]
Dtsch Med Wochenschr. 2004 Sep 3;129(36):1849-53. doi: 10.1055/s-2004-831347.
9
Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.慢性血液透析患者对重组人促红细胞生成素的依赖性:临床特征、铁稳态与红细胞生成
Clin Nephrol. 2005 Feb;63(2):92-7. doi: 10.5414/cnp63092.
10
Effects of additional iron doses on hepcidin-25 level in hemodialysis patients without evident iron deficiency.额外铁剂量对无明显铁缺乏的血液透析患者中hepcidin-25水平的影响。
Int Urol Nephrol. 2014 May;46(5):1005-12. doi: 10.1007/s11255-014-0696-z. Epub 2014 Mar 29.

引用本文的文献

1
Combined predictive value of prognostic nutritional index and neutrophil to lymphocyte ratio for all-cause mortality risk in maintenance hemodialysis patients: a cohort study followed for 5 years.预后营养指数和中性粒细胞与淋巴细胞比值对维持性血液透析患者全因死亡风险的联合预测价值:一项为期5年的队列研究
BMC Nephrol. 2025 Jul 1;26(1):319. doi: 10.1186/s12882-025-04273-2.
2
Impact of transferrin saturation on cardiovascular events in non-dialysis-dependent chronic kidney disease patients treated with darbepoetin alfa.转铁蛋白饱和度对接受阿法达贝泊汀治疗的非透析依赖性慢性肾脏病患者心血管事件的影响。
J Nephrol. 2024 Nov;37(8):2327-2335. doi: 10.1007/s40620-024-02000-y. Epub 2024 Jun 28.
3

本文引用的文献

1
Benefits and risks of essential trace elements in chronic kidney disease: a narrative review.慢性肾脏病中必需微量元素的益处与风险:一项叙述性综述
Ann Transl Med. 2022 Dec;10(24):1400. doi: 10.21037/atm-22-5969.
2
Clinical significance of hemodialysis quality of care indicators in very elderly patients with end stage kidney disease.高龄终末期肾病患者血液透析护理质量指标的临床意义
J Nephrol. 2022 Dec;35(9):2351-2361. doi: 10.1007/s40620-022-01356-3. Epub 2022 Jun 6.
3
Iron Metabolism in Aging and Age-Related Diseases.铁代谢与衰老和衰老相关疾病。
Changes in pre-haemodialysis serum creatinine levels over 2 years and long-term survival in maintenance haemodialysis.
维持性血液透析患者2年内透析前血清肌酐水平的变化及长期生存情况
J Cachexia Sarcopenia Muscle. 2024 Aug;15(4):1568-1577. doi: 10.1002/jcsm.13515. Epub 2024 Jun 18.
Int J Mol Sci. 2022 Mar 25;23(7):3612. doi: 10.3390/ijms23073612.
4
Iron Deficiency is Associated With Platelet Count Elevation in Patients With Dialysis-dependent Chronic Kidney Disease.缺铁与依赖透析的慢性肾病患者血小板计数升高有关。
J Ren Nutr. 2022 Sep;32(5):587-594. doi: 10.1053/j.jrn.2021.09.004. Epub 2022 Mar 24.
5
Serum Hepcidin-25 and All-Cause Mortality in Patients Undergoing Maintenance Hemodialysis.维持性血液透析患者的血清铁调素-25与全因死亡率
Int J Gen Med. 2021 Jul 5;14:3153-3162. doi: 10.2147/IJGM.S313777. eCollection 2021.
6
Serum Hepcidin-25 and Risk of Mortality in Patients on Peritoneal Dialysis.血清铁调素-25与腹膜透析患者的死亡风险
Front Med (Lausanne). 2021 Jun 17;8:684548. doi: 10.3389/fmed.2021.684548. eCollection 2021.
7
Abnormal iron status is associated with an increased risk of mortality in patients on peritoneal dialysis.异常的铁状态与腹膜透析患者的死亡率增加有关。
Nutr Metab Cardiovasc Dis. 2021 Apr 9;31(4):1148-1155. doi: 10.1016/j.numecd.2020.12.018. Epub 2021 Feb 19.
8
Relationship between serum hepcidin levels and cardiovascular disease in patients with maintenance hemodialysis.维持性血液透析患者血清 hepcidin 水平与心血管疾病的关系。
Physiol Int. 2020 Dec 18;107(4):491-500. doi: 10.1556/2060.2020.00040.
9
Iron deficiency and iron therapy in heart failure and chronic kidney disease.心力衰竭和慢性肾脏病中的铁缺乏和铁治疗。
Curr Opin Nephrol Hypertens. 2020 Sep;29(5):508-514. doi: 10.1097/MNH.0000000000000630.
10
Impact of Transferrin Saturation on All-Cause Mortality in Patients on Maintenance Hemodialysis.转铁蛋白饱和度对维持性血液透析患者全因死亡率的影响。
Blood Purif. 2019;48(2):158-166. doi: 10.1159/000499758. Epub 2019 Jul 16.